[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2010056044A3 - 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물 - Google Patents

바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물 Download PDF

Info

Publication number
WO2010056044A3
WO2010056044A3 PCT/KR2009/006631 KR2009006631W WO2010056044A3 WO 2010056044 A3 WO2010056044 A3 WO 2010056044A3 KR 2009006631 W KR2009006631 W KR 2009006631W WO 2010056044 A3 WO2010056044 A3 WO 2010056044A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
isomer
pharmaceutically acceptable
acceptable salt
novel compound
Prior art date
Application number
PCT/KR2009/006631
Other languages
English (en)
French (fr)
Other versions
WO2010056044A2 (ko
Inventor
김선영
백흥수
김연준
남미희
우병영
정연수
김혁
윤정훈
임경민
최진규
고현주
서정아
이지해
주영협
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020090022704A external-priority patent/KR101367057B1/ko
Priority claimed from KR1020090065107A external-priority patent/KR101252335B1/ko
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Publication of WO2010056044A2 publication Critical patent/WO2010056044A2/ko
Publication of WO2010056044A3 publication Critical patent/WO2010056044A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 바닐로이드 수용체(Vanilloid Receptor 1; VR1; TRPV1) 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염; 및 이를 포함하는 약학 조성물에 관한 것이다. 본 발명은 통증, 편두통(migraine), 관절통(arthralgia), 신경통(neuralgia), 신경장해(neuropathies), 신경 손상(nerve injury), 피부 질환(skin disorder), 비뇨 방광 과민증(urinary bladder hypersensitiveness), 과민성 대장 증후군(irritable bowel syndrome), 절박배변(fecal urgency), 호흡기 질환(respiratory disorder), 위-십이지장 궤양(stomach-duodenal ulcer), 염증 질병(inflammatory diseases), 귓병(ear disease), 심장병(heart disease) 등과 같은 질병의 예방 또는 치료용 약학 조성물을 제공하며, 피부 노화 방지용 조성물 또는 피부 자극 완화용 조성물을 제공한다.
PCT/KR2009/006631 2008-11-11 2009-11-11 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물 WO2010056044A2 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11336008P 2008-11-11 2008-11-11
US61/113,360 2008-11-11
KR1020090022704A KR101367057B1 (ko) 2009-03-17 2009-03-17 피부 자극 완화용 조성물
KR10-2009-0022704 2009-03-17
KR1020090065107A KR101252335B1 (ko) 2009-07-16 2009-07-16 피부 노화 방지용 조성물
KR10-2009-0065107 2009-07-16

Publications (2)

Publication Number Publication Date
WO2010056044A2 WO2010056044A2 (ko) 2010-05-20
WO2010056044A3 true WO2010056044A3 (ko) 2010-10-21

Family

ID=42170519

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/006631 WO2010056044A2 (ko) 2008-11-11 2009-11-11 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물

Country Status (1)

Country Link
WO (1) WO2010056044A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3401307A1 (en) * 2017-05-11 2018-11-14 Antalgenics, S.L. Trpv1 modulator compounds

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003084A1 (en) * 2003-07-02 2005-01-13 Grunenthal Gmbh 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same
WO2006097817A1 (en) * 2005-03-17 2006-09-21 Pfizer Japan Inc. N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
WO2007041634A1 (en) * 2005-10-04 2007-04-12 Aventis Pharmaceuticals Inc. Pyrimidine amide compounds as pgds inhibitors
WO2009064449A1 (en) * 2007-11-13 2009-05-22 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003084A1 (en) * 2003-07-02 2005-01-13 Grunenthal Gmbh 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same
WO2006097817A1 (en) * 2005-03-17 2006-09-21 Pfizer Japan Inc. N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
WO2007041634A1 (en) * 2005-10-04 2007-04-12 Aventis Pharmaceuticals Inc. Pyrimidine amide compounds as pgds inhibitors
WO2009064449A1 (en) * 2007-11-13 2009-05-22 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Also Published As

Publication number Publication date
WO2010056044A2 (ko) 2010-05-20

Similar Documents

Publication Publication Date Title
TW200716522A (en) Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
WO2009096701A3 (en) Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
WO2009106980A3 (en) Indazole derivatives
AU2001280230A1 (en) Novel thiourea compounds and the pharmaceutical compositions containing the same
EA021275B9 (ru) Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания
MX2010003346A (es) Piperazino-dihidrotienopirimidinas sustituidas en heterociclo.
IL184932A0 (en) Glucagon receptor antagonists, preperation and therapeutic uses
MA28706B1 (fr) Antagoniste des recepteurs du glucagon, preparation et utilisations therapeutiques
WO2009063202A3 (en) Use of crth2 antagonist compounds
WO2008097428A3 (en) Compounds and compositions as modulators of gpr119 activity
WO2008157751A3 (en) Substituted imidazoheterocycles
WO2007106181A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
DE602006012725D1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
DE602005018758D1 (de) Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
WO2007120270A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
ATE473961T1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
MY161607A (en) Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
TW200611695A (en) Pyrrolopyridine derivatives
WO2006052889A3 (en) Quinolinone-carboxamide compounds
WO2008116663A3 (en) Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
WO2009082526A3 (en) Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
MX2009000763A (es) Derivados ciclicos como moduladores de la actividad del receptor de quimiocina.
TW200631945A (en) The aromatic amide derivatives, the pharmaceutical composition comprising the same and its medical application
ATE523488T1 (de) Histamin-h3-rezeptor-mittel, deren herstellung und therapeutische verwendung

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09826276

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09826276

Country of ref document: EP

Kind code of ref document: A2